How GLP-1 weight loss drugs are reshaping the healthcare industry
A new report says GLP-1 weight loss drugs drove a 34.1% drop in bariatric surgery volumes as semaglutide reshapes how hospitals generate revenue.
Featured for 1062 minutes •
153 points